Aldeyra Therapeutics, Inc. (ALDX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

($107.07K) Net Amount

Buy:	0	--
Sell:	($107.07K)	$3.41

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

2

(2)

1

(1)

14

0

1

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Mar-24 8:01 PM View:	12-Mar-24 Sale ($260.24K)	Brady Todd C President and CEO Director		Aldeyra Therapeutics, Inc. - ALDX	(11%) 1.65M to 1.47M	0	0	--	--	Show Txns Hide Txns

08-Apr-24 5:32 PM View:	05-Apr-24 Purchase $178.76K	Perceptive Advisors LLC 10% Owner		Aldeyra Therapeutics, Inc. - ALDX	8% 8.59M to 9.28M	0	0	--	--	Show Txns Hide Txns

14-Aug-24 4:24 PM View:	12-Aug-24 Private Sale ($75.98K)	MacHatha Stephen Chief Development Officer		Aldeyra Therapeutics, Inc. - ALDX	(13%) 273.47K to 236.77K	0	($62.10K) (7%)	--	$3.41	Show Txns Hide Txns

14-Aug-24 4:24 PM View:	12-Aug-24 Private Sale ($51.31K)	Greenberg Bruce See Remarks		Aldeyra Therapeutics, Inc. - ALDX	(6%) 133.9K to 126.38K	0	($44.97K) (10%)	--	$3.41	Show Txns Hide Txns